Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preparing healthcare providers to use polygenic risk scores: a qualitative study of learning needs and educational preferences.

BMJ open·2026
Same author

AK8 deficiency causes primary ciliary dyskinesia by disrupting energy homeostasis in the airways.

American journal of respiratory and critical care medicine·2026
Same author

Genotype- dermatological phenotype correlations in CDKN2A, POT1, POLE, BAP1 variant carriers using 3D total-body-imaging.

The British journal of dermatology·2026
Same author

Incubating artificial intelligence initiatives and careers in dermatology.

The Journal of investigative dermatology·2026
Same author

Population-Based Melanoma Screening Using Integrated Risk Scores in Australia: A Narrative Review to Determine Readiness.

The Medical journal of Australia·2026
Same author

Consumer and community involvement in health research in Australia: evaluation of researcher training workshops.

Public health research & practice·2026

Related Experiment Video

Updated: Jul 4, 2025

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model
10:23

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

Published on: November 13, 2012

13.7K

Genetic testing for familial melanoma.

Clare A Primiero1,2, Ellie J Maas1, Courtney K Wallingford1

  • 1Frazer Institute, Dermatology Research Centre, The University of Queensland, Brisbane, Australia.

Italian Journal of Dermatology and Venereology
|January 30, 2024
PubMed
Summary

Familial melanoma genetic testing identifies individuals with high inherited risk. Early detection and genetic counseling improve sun protection and screening behaviors in mutation carriers.

More Related Videos

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
05:58

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Published on: August 20, 2018

10.9K
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

8.7K

Related Experiment Videos

Last Updated: Jul 4, 2025

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model
10:23

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

Published on: November 13, 2012

13.7K
Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
05:58

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Published on: August 20, 2018

10.9K
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

8.7K

Area of Science:

  • Genetics
  • Dermatology
  • Oncology

Background:

  • Inherited mutations significantly increase melanoma risk (52-84%) compared to the average (3%).
  • Familial melanoma testing criteria vary by country incidence, requiring 2-4 affected relatives.
  • CDKN2A mutations are common, but multi-gene panels enhance diagnostic yield.

Purpose of the Study:

  • To review current practices and propose a mainstream model for familial melanoma genetic testing.
  • To highlight the role of dermatologists in identifying high-risk individuals.
  • To emphasize the importance of pre- and post-test genetic counseling.

Main Methods:

  • Review of existing literature on familial melanoma genetics and testing.
  • Analysis of diagnostic yield with single-gene versus multi-gene panel testing.
  • Discussion of current genetic counseling models and potential for mainstreaming in dermatology.

Main Results:

  • Multi-gene panels increase the diagnostic yield for familial melanoma risk genes.
  • Mutation carriers show improved sun protective behaviors and screening frequency post-testing.
  • Genetic testing requires informed consent covering results, limitations, and discrimination risks.

Conclusions:

  • A mainstream model for melanoma genetic testing, with trained dermatologists, could meet increasing demand.
  • Integrating genetic testing into dermatology clinics requires appropriate training and pre/post-test counseling.
  • Genetic testing empowers individuals with knowledge to improve melanoma prevention and early detection strategies.